Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

CARL JACK FICHTENBAUM

Allopathic & Osteopathic Physicians Internal Medicine Infectious Disease

NPI
1073578951
CMS profile
2920
Location
CINCINNATI, OH

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2025 · Entire year

$2,462.10

13 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2025 · entire year · sorted by reported total

Nature of paymentAmountRecords
Travel and Lodging $1,086.39 4
Food and Beverage $795.71 8
Consulting Fee $580.00 1

By paying entity

PY2025 · entire year · sorted by reported total

Paying entityAmountRecords
Merck Sharp & Dohme LLC $1,911.31 8
ViiV Healthcare Company $238.20 2
Gilead Sciences, Inc. $166.37 2
La Jolla Pharmaceutical Company $146.22 1

Page 1 of 1; records 1–13 of 13 matching records. This page contains 13 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

CARL JACK FICHTENBAUM

NPI 1073578951 · CMS profile ID 2920

Allopathic & Osteopathic Physicians / Internal Medicine / Infectious Disease

CINCINNATI, OH

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 1 of 1; records 1–13 of 13 matching records. This page contains 13 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1073578951?year=2025&recipient=provider#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
CARL JACK FICHTENBAUM, NPI 1073578951, CMS profile ID 2920. General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–13 of 13 matching records. This page contains 13 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1073578951?year=2025&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e.
APA 7
IndustryPayments. (2026). CARL JACK FICHTENBAUM, NPI 1073578951, CMS profile ID 2920. General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–13 of 13 matching records. This page contains 13 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1073578951?year=2025&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e.
Bluebook
CARL JACK FICHTENBAUM, NPI 1073578951, CMS profile ID 2920, IndustryPayments, General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 1 of 1; records 1–13 of 13 matching records. This page contains 13 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e. https://industrypayments.org/provider/npi-1073578951?year=2025&recipient=provider#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2025 · Physicians and non-physician practitioners · CMS publication 2026-06-30

13 matching records · $2,462.10 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 13 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 1–13 of 13.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Merck Sharp & Dohme LLC $580.0012/15/2025 Consulting Fee No dispute reported Delay: No
Change: NEW
06/30/2026 1238002278 CMS
Merck Sharp & Dohme LLC $29.9412/04/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1238006172 CMS
Merck Sharp & Dohme LLC $64.9812/04/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1238036072 CMS
Merck Sharp & Dohme LLC $232.0012/03/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1237998910 CMS
Merck Sharp & Dohme LLC $185.4912/03/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1238030236 CMS
Merck Sharp & Dohme LLC $562.4012/03/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1238031316 CMS
Merck Sharp & Dohme LLC $106.5012/03/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1238037994 CMS
Merck Sharp & Dohme LLC $150.0012/03/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1238038900 CMS
La Jolla Pharmaceutical Company $146.2210/20/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1237493631 CMS
Gilead Sciences, Inc. $97.7510/19/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1234402732 CMS
ViiV Healthcare Company $113.6410/19/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1189593598 CMS
Gilead Sciences, Inc. $68.6203/10/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1234409515 CMS
ViiV Healthcare Company $124.5601/20/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1189512754 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $28.43 1
PY2021 $99.00 1
PY2022 $6,617.41 7
PY2023 $2,560.30 16
PY2024 $249.93 3
PY2025 $2,462.10 13

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Source files
Dataset page · Bulk file · PY2019 , PY2021 , PY2022 , PY2023 , PY2024 , PY2025
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Recipient $1,213.04 4
PY2025 Principal investigator $578,272.21 59
PY2024 Recipient $473.50 2
PY2024 Principal investigator $223,284.75 51
PY2023 Recipient $1,149.35 11
PY2023 Principal investigator $65,128.22 19
PY2022 Principal investigator $109,613.44 27
PY2021 Recipient $12,898.30 1
PY2021 Principal investigator $167,018.23 49
PY2020 Principal investigator $181,285.60 70
PY2019 Principal investigator $263,157.10 91

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2022

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

27 records in PY2022

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 ModernaTX, Inc. $21,458.25 12/01/2022 Non-covered Recipient Entity
UNIVERSITY OF CINCINNATI
A Phase 3b, Open-Label, Safety and Immunogenicity Study of SARS CoV 2 mRNA-1273 Vaccine in Adult Solid Organ Transplant Recipients and Healthy Controls No dispute reported 06/30/2026 963688853
Principal investigator 1 ViiV Healthcare Company $4,600.00 11/23/2022 Non-covered Recipient Entity
UC HEALTH
A PHASE IIB, RANDOMIZED, DOUBLE-BLIND, PARALLEL-GROUP STUDY TO ASSESS No dispute reported 06/30/2026 943808037
Principal investigator 1 ViiV Healthcare Company $390.00 11/17/2022 Non-covered Recipient Entity
UNIVERSITY OF CINCINNATI
A PHASE IIIB, RANDOMIZED, MULTICENTER, PARALLEL-GROUP, NON-INFERIORITY No dispute reported 06/30/2026 943808043
Principal investigator 1 ViiV Healthcare Company $300.00 11/17/2022 Non-covered Recipient Entity
UNIVERSITY OF CINCINNATI
A PHASE IIIB, RANDOMIZED, MULTICENTER, PARALLEL-GROUP, NON-INFERIORITY No dispute reported 06/30/2026 943808047
Principal investigator 1 ViiV Healthcare Company $1,250.00 11/17/2022 Non-covered Recipient Entity
UNIVERSITY OF CINCINNATI
A PHASE IIIB, RANDOMIZED, MULTICENTER, PARALLEL-GROUP, NON-INFERIORITY No dispute reported 06/30/2026 943808059
Principal investigator 1 ViiV Healthcare Company $390.00 11/17/2022 Non-covered Recipient Entity
UNIVERSITY OF CINCINNATI
A PHASE IIIB, RANDOMIZED, MULTICENTER, PARALLEL-GROUP, NON-INFERIORITY No dispute reported 06/30/2026 943808063
Principal investigator 1 ViiV Healthcare Company $1,250.00 11/17/2022 Non-covered Recipient Entity
UNIVERSITY OF CINCINNATI
A PHASE IIIB, RANDOMIZED, MULTICENTER, PARALLEL-GROUP, NON-INFERIORITY No dispute reported 06/30/2026 943808073
Principal investigator 1 ViiV Healthcare Company $300.00 11/17/2022 Non-covered Recipient Entity
UNIVERSITY OF CINCINNATI
A PHASE IIIB, RANDOMIZED, MULTICENTER, PARALLEL-GROUP, NON-INFERIORITY No dispute reported 06/30/2026 943808079
Principal investigator 1 ABBVIE INC. $7,000.00 11/01/2022 Non-covered Recipient Entity
UNIVERSITY OF CINCINNATI
A Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of ABBV-181 (Budigalimab) in Adult Participants With Human Immunodeficiency Virus (HIV)-1 No dispute reported 06/30/2026 889817869
Principal investigator 1 ModernaTX, Inc. $13,500.00 10/28/2022 Non-covered Recipient Entity
UNIVERSITY OF CINCINNATI
A Phase 3b, Open-Label, Safety and Immunogenicity Study of SARS CoV 2 mRNA-1273 Vaccine in Adult Solid Organ Transplant Recipients and Healthy Controls No dispute reported 06/30/2026 963688807
Principal investigator 1 ModernaTX, Inc. $4,320.00 10/28/2022 Non-covered Recipient Entity
UNIVERSITY OF CINCINNATI
A Phase 3b, Open-Label, Safety and Immunogenicity Study of SARS CoV 2 mRNA-1273 Vaccine in Adult Solid Organ Transplant Recipients and Healthy Controls No dispute reported 06/30/2026 963688809
Principal investigator 1 ModernaTX, Inc. $3,645.00 10/28/2022 Non-covered Recipient Entity
UNIVERSITY OF CINCINNATI
A Phase 3b, Open-Label, Safety and Immunogenicity Study of SARS CoV 2 mRNA-1273 Vaccine in Adult Solid Organ Transplant Recipients and Healthy Controls No dispute reported 06/30/2026 963688811
Principal investigator 1 ModernaTX, Inc. $843.75 10/28/2022 Non-covered Recipient Entity
UNIVERSITY OF CINCINNATI
A Phase 3b, Open-Label, Safety and Immunogenicity Study of SARS CoV 2 mRNA-1273 Vaccine in Adult Solid Organ Transplant Recipients and Healthy Controls No dispute reported 06/30/2026 963688813
Principal investigator 1 ViiV Healthcare Company $14,545.11 09/22/2022 Covered Recipient Teaching Hospital
UNIVER.OF CINCINNATI MED CENTER LLC
A PHASE IIB, RANDOMIZED, DOUBLE-BLIND, PARALLEL-GROUP STUDY TO ASSESS No dispute reported 06/30/2026 943808027
Principal investigator 1 ViiV Healthcare Company $7,154.89 09/22/2022 Covered Recipient Teaching Hospital
UNIVER.OF CINCINNATI MED CENTER LLC
A PHASE IIB, RANDOMIZED, DOUBLE-BLIND, PARALLEL-GROUP STUDY TO ASSESS No dispute reported 06/30/2026 943808033
Principal investigator 1 ViiV Healthcare Company $3,278.29 08/15/2022 Non-covered Recipient Entity
UNIVERSITY OF CINCINNATI
A PHASE IIIB, RANDOMIZED, MULTICENTER, PARALLEL-GROUP, NON-INFERIORITY No dispute reported 06/30/2026 943808053
Principal investigator 1 ViiV Healthcare Company $390.00 08/15/2022 Non-covered Recipient Entity
UNIVERSITY OF CINCINNATI
PH 3 HIV TWO-YEAR NON-INFERIORITY COMPARED TO STANDARD OF CARE SAFETY/ No dispute reported 06/30/2026 943808091
Principal investigator 1 ViiV Healthcare Company $390.00 08/15/2022 Non-covered Recipient Entity
UNIVERSITY OF CINCINNATI
PH 3 HIV TWO-YEAR NON-INFERIORITY COMPARED TO STANDARD OF CARE SAFETY/ No dispute reported 06/30/2026 943808097
Principal investigator 1 ViiV Healthcare Company $1,500.00 08/15/2022 Non-covered Recipient Entity
UNIVERSITY OF CINCINNATI
PH 3 HIV TWO-YEAR NON-INFERIORITY COMPARED TO STANDARD OF CARE SAFETY/ No dispute reported 06/30/2026 943808109
Principal investigator 1 ViiV Healthcare Company $1,500.00 08/15/2022 Non-covered Recipient Entity
UNIVERSITY OF CINCINNATI
PH 3 HIV TWO-YEAR NON-INFERIORITY COMPARED TO STANDARD OF CARE SAFETY/ No dispute reported 06/30/2026 943808113
Principal investigator 1 Gilead Sciences, Inc. $5,340.00 06/15/2022 Non-covered Recipient Entity
UNIVERSITY OF CINCINNATI PHYSICIANS COMPANY
A Phase 3, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of GS-9883/Emtricitabine/Tenofovir Alafenamide Versus Dolutegravir + Emtricitabine/Tenofovir Alafenamide in HIV-1 Infected, Antiretroviral Treatment-Naive Adults No dispute reported 06/30/2026 920358319
Principal investigator 1 ViiV Healthcare Company $3,276.00 06/02/2022 Non-covered Recipient Entity
UNIVERSITY OF CINCINNATI
PH 3 HIV TWO-YEAR NON-INFERIORITY COMPARED TO STANDARD OF CARE SAFETY/ No dispute reported 06/30/2026 943808103
Principal investigator 1 Gilead Sciences, Inc. $2,490.00 06/01/2022 Non-covered Recipient Entity
UNIVERSITY OF CINCINNATI PHYSICIANS COMPANY
A Phase 3, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of GS- 9883/Emtricitabine/Tenofovir Alafenamide Versus Abacavir/Dolutegravir/Lamivudine in HIV- 1 Infected, Antiretroviral Treatment-Naive Adults No dispute reported 06/30/2026 920358317
Principal investigator 1 ViiV Healthcare Company $1,614.60 03/10/2022 Non-covered Recipient Entity
UNIVERSITY OF CINCINNATI PHYSICIANS CO
PH 3 HIV TWO-YEAR NON-INFERIORITY COMPARED TO STANDARD OF CARE SAFETY/ No dispute reported 06/30/2026 943808085
Principal investigator 1 Gilead Sciences, Inc. $1,100.00 02/02/2022 Non-covered Recipient Entity
UNIVERSITY OF CINCINNATI PHYSICIANS COMPANY
A Phase 3, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of Fixed Dose Combination of Bictegravir/Emtricitabine/Tenofovir Alafenamide versus Dolutegravir + Emtricitabine/Tenofovir Disoproxil Fumarate in Treatment Naive, HIV-1 and Hepatitis B Co-Infected Adults No dispute reported 06/30/2026 920358315
Principal investigator 1 ViiV Healthcare Company $5,687.55 01/31/2022 Non-covered Recipient Entity
UNIVERSITY OF CINCINNATI
A PHASE IIIB, RANDOMIZED, MULTICENTER, PARALLEL-GROUP, NON-INFERIORITY No dispute reported 06/30/2026 943808069
Principal investigator 1 Gilead Sciences, Inc. $2,100.00 01/26/2022 Non-covered Recipient Entity
UNIVERSITY OF CINCINNATI PHYSICIANS COMPANY
A Phase 2 Randomized, Open Label, Active Controlled Study Evaluating the Safety and Efficacy of Long-acting Capsid Inhibitor GS-6207 in Combination with Other Antiretroviral Agents in People Living with HIV No dispute reported 06/30/2026 920349337